These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17122237)

  • 1. The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4).
    Kang JG; Ahn HJ; Kim GS; Hahm TS; Lee JJ; Gwak MS; Choi SJ
    Anesth Analg; 2006 Dec; 103(6):1543-8. PubMed ID: 17122237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies.
    Jones PA; Tomasic M; Gentry PA
    Am J Vet Res; 1997 May; 58(5):541-8. PubMed ID: 9140565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral effect of acute normovolemic hemodilution during brain tumor resection.
    Daif AA; Hassan YM; Ghareeb NA; Othman MM; Mohamed SA
    J Neurosurg Anesthesiol; 2012 Jan; 24(1):19-24. PubMed ID: 21904221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
    Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms.
    Jin SL; Yu BW
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):91-8. PubMed ID: 19825916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of acute normovolemic hemodilution and acute hypervolemic hemodilution on coagulation and allogeneic transfusion.
    Saricaoglu F; Akinci SB; Celiker V; Aypar U
    Saudi Med J; 2005 May; 26(5):792-8. PubMed ID: 15951872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
    Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Volume substitution in acute normovolemic hemodilution. 5% human albumin vs. 6% hydroxyethyl starch].
    von Bormann B; Sticher J; Ratthey K; Idelberger R; Hempelmann G
    Infusionstherapie; 1990 Jun; 17(3):142-6. PubMed ID: 1697284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery.
    Habler O; Schwenzer K; Zimmer K; Prager M; König U; Oppenrieder K; Pape A; Steinkraus E; Reither A; Buchrot A; Zwissler B
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):467-75. PubMed ID: 15183411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in blood coagulation in treatment with hydroxyethyl starch].
    Sefrin P; Rauch S; Zieglmeyer C
    Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
    Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
    Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution.
    Haas T; Fries D; Holz C; Innerhofer P; Streif W; Klingler A; Hanke A; Velik-Salchner C
    Anesth Analg; 2008 Apr; 106(4):1078-86, table of contents. PubMed ID: 18349176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
    Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ABO blood group on the collagen-binding assay for von Willebrand factor.
    Haley E; Babar N; Ritter C; Downes KA; Green D; Shurin S; Sarode R
    Am J Hematol; 2002 Nov; 71(3):229-31. PubMed ID: 12410584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.